Jubilant Ingrevia Ltd Falls to 52-Week Low Amidst Continued Downtrend

Stock Price Movement and Market Context

On 2 March 2026, Jubilant Ingrevia Ltd’s shares opened sharply lower with an 8.61% gap down, hitting an intraday low of Rs.535.3, the lowest level in the past year. This decline extended a five-day losing streak during which the stock has fallen by 6.49%. The day’s performance saw the stock underperform its specialty chemicals sector by 2.06%, further emphasising the relative weakness in its price action.

Technical indicators show the stock trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, signalling a persistent bearish trend. In contrast, the broader Sensex index, despite opening 2,743.46 points lower, managed a partial recovery and was trading at 79,740.90 points, down 1.9% on the day. The Sensex remains below its 50-day moving average, though the 50DMA is positioned above the 200DMA, indicating mixed signals for the overall market.

Over the past year, Jubilant Ingrevia Ltd’s stock has declined by 7.89%, underperforming the Sensex’s 8.92% gain over the same period. The stock’s 52-week high was Rs.851.85, highlighting the extent of the recent correction.

Financial Performance and Key Metrics

Jubilant Ingrevia Ltd’s long-term financial performance has been subdued. Over the last five years, net sales have declined at an annualised rate of 0.45%, while operating profit has contracted more sharply at an annual rate of 13.67%. This trend has contributed to the stock’s weak returns and diminished investor confidence.

In the most recent quarter, the company reported a profit after tax (PAT) of Rs.56.25 crore, representing a 21.9% decrease compared to the average of the previous four quarters. This decline in profitability has weighed on the stock’s valuation and market perception.

Operational efficiency indicators also reflect challenges. The debtors turnover ratio for the half-year period stands at a low 5.56 times, indicating slower collection cycles. Additionally, the operating profit to interest coverage ratio for the quarter is at 10.16 times, the lowest recorded, suggesting tighter margins for servicing debt obligations.

Despite these concerns, the company maintains a relatively strong debt servicing capacity, with a low debt to EBITDA ratio of 1.20 times. This level of leverage is manageable and provides some cushion against financial strain.

Return on capital employed (ROCE) is reported at 10.6%, which, coupled with an enterprise value to capital employed ratio of 2.7, points to an attractive valuation relative to capital utilisation. The stock is trading at a discount compared to its peers’ average historical valuations, reflecting the market’s cautious stance.

Interestingly, while the stock has generated a negative return of 7.89% over the past year, the company’s profits have increased by 33.2% during the same period. The price/earnings to growth (PEG) ratio stands at 1, indicating that the stock’s valuation is aligned with its earnings growth rate.

Shareholding and Market Sentiment

Institutional investors hold a significant stake in Jubilant Ingrevia Ltd, accounting for 30.17% of the share capital. This group has increased its holdings by 1.15% over the previous quarter, signalling continued interest from entities with greater analytical resources and market insight.

Nevertheless, the company’s Mojo Score remains low at 28.0, with a Mojo Grade of Strong Sell as of 5 February 2026, downgraded from Sell. The market capitalisation grade is rated 3, reflecting moderate size but limited momentum in price appreciation.

Comparative Performance and Sector Positioning

Jubilant Ingrevia Ltd’s underperformance is evident when compared to the BSE500 index, where it has lagged over the last three years, one year, and three months. This persistent underperformance highlights the challenges the company faces in regaining investor confidence and market share within the specialty chemicals sector.

The sector itself has shown resilience, with the Sensex recovering from its initial gap down on the day of the stock’s new low. However, Jubilant Ingrevia’s stock remains pressured, reflecting company-specific factors rather than broader market trends.

While the company’s valuation metrics suggest some appeal, the combination of declining sales, reduced profitability, and subdued returns over multiple time frames has contributed to the current market stance.

Summary of Key Data Points

• New 52-week low price: Rs.535.3
• Five consecutive days of decline, totalling a 6.49% loss
• Yearly stock return: -7.89% versus Sensex +8.92%
• Five-year net sales growth: -0.45% annually
• Five-year operating profit decline: -13.67% annually
• Latest quarter PAT: Rs.56.25 crore, down 21.9%
• Debtors turnover ratio (HY): 5.56 times
• Operating profit to interest coverage (Q): 10.16 times
• Debt to EBITDA ratio: 1.20 times
• ROCE: 10.6%
• Enterprise value to capital employed: 2.7
• Institutional holdings: 30.17%, increased by 1.15% last quarter
• Mojo Score: 28.0 (Strong Sell), downgraded from Sell on 5 Feb 2026

Jubilant Ingrevia Ltd’s stock performance and financial indicators reflect a period of subdued growth and valuation pressures. The recent 52-week low underscores the challenges faced by the company in the current market environment.

Limited Period Only. Start at Rs. 9,999 - Get MojoOne for 1 Year + 3 Months FREE (60% Off) Get 71% Off →